Search Results for "New Treatment For Hepatitis B"

08:39 EDT 29th August 2015 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis B?related PAN

Fulminant Hepatitis

Matching News

Hepatitis C: Life-threatening barriers in access to breakthrough drugs in US

Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C. According to a team of researchers who examined Medicaid p...

NICE restricts access to new hepatitis C treatments

NICE has recommended three new treatment options for hepatitis C in draft guidance - but has been criticised for excluding major patient groups from treatment with some drugs.  The draft guidance...

NICE recommends Harvoni for hepatitis C

NICE has signalled a provisional OK for Gilead’s Harvoni to be used as a treatment for hepatitis C by the NHS. In draft guidance the healthcare watchdog approved Harvoni (ledipasvir-sofosbuvir) as a...

Mass. Prisoners Sue to Get Hepatitis Treatment

Two prisoners have sued the Massachusetts Department of Corrections to get access to the latest hepatitis treatments. The two inmates, Emilian Paszko and Jeffrey Fowler, argue that the prison system ...

WHO calls for urgent action to curb hepatitis

On World Hepatitis Day (28 July) WHO highlights the urgent need for countries to enhance action to prevent viral hepatitis infection and to ensure that people who have been infected are diagnosed and...

How hepatitis C treatment is a glimpse of health care’s future

Hepatitis C is one of the most common chronic infectious illnesses in the U.S. today and affects nearly 3.2 million Americans. Complications of hepatitis C infection include liver cancer as well as ci...

Modelling hepatitis C therapy—predicting effects of treatment

Mathematical modelling of the viral kinetics of hepatitis C infection can help inform clinicians of the optimal treatment regimens to achieve a sustained virologic response. In...

Global Expansion of Hepatitis Vaccination Needed to Hasten Hepatitis B Elimination

Results revealed today at the International Liver Congress™ 2015 demonstrate current treatment and prevention programmes need to be scaled up in order to make elimination of hepatitis B virus (H...

Matching PubMed Articles

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus co-infected patients from Sub-Saharan Africa.

In Sub-Saharan Africa, seroclearance of hepatitis B surface antigen (HBsAg) and hepatitis B "e" antigen (HBeAg), including their quantifiable markers, have rarely been evaluated during long-term antiv...

Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon.

With 3-4 million of new infections occurring annually, hepatitis C virus (HCV) infection is a global Public Health problem. In fact, hepatitis C virus infection is one of the leading causes of liver d...

Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis.

A wide variety of competing drugs are available to patients for the treatment of chronic hepatitis B. We update a recent meta-analysis to include additional trial evidence with the aim of determining ...

Personalized treatment of hepatitis B.

There are seven approved drugs for treatment of hepatitis B. Professional guidelines provide a framework for managing patients but these guidelines should be interpreted in the context of the individu...

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.

Chronic hepatitis C virus infection is a major cause of liver disease in Switzerland and carries a significant cost burden. Currently, only conservative strategies are in place to mitigate the burden ...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement